Cyclerion Therapeutics (CYCN) Total Current Liabilities (2018 - 2025)

Cyclerion Therapeutics' Total Current Liabilities history runs 8 years deep, the most recent figure standing at $900000.0 for Q4 2025.

• In Q4 2025, Total Current Liabilities rose 24.14% year-over-year to $900000.0; the TTM figure through Dec 2025 stood at $900000.0 (up 24.14% YoY), while the FY2025 annual figure was $900000.0, up 24.14% from the prior year.
• Total Current Liabilities was $900000.0 for Q4 2025 at Cyclerion Therapeutics, up from $877000.0 in the prior quarter.
• In the past five years, Total Current Liabilities ranged from a high of $13.5 million in Q1 2021 to a low of $700000.0 in Q3 2024.
• Historically, Total Current Liabilities has averaged $5.3 million across 5 years, with a median of $3.6 million in 2023.
• The sharpest annual moves came in 2024 and 2025: Total Current Liabilities sank 80.87% in 2024, then gained 25.29% in 2025.
• A 5-year view of Total Current Liabilities shows it stood at $11.1 million in 2021, then sank by 31.2% to $7.6 million in 2022, then plunged by 72.65% to $2.1 million in 2023, then slumped by 65.24% to $725000.0 in 2024, then increased by 24.14% to $900000.0 in 2025.
• The last three Total Current Liabilities figures came in at $900000.0 (Q4 2025), $877000.0 (Q3 2025), and $800000.0 (Q2 2025), per Business Quant data.